eMurmur ID vs EchoNext
AI Verdict
Choose eMurmur ID if…
Choose eMurmur ID if your primary need is AI-powered detection and classification of heart murmurs using an electronic stethoscope, particularly for real-time decision support during auscultation or for remote consultations. It's ideal for healthcare providers who want to enhance their cardiac auscultation skills, reduce inappropriate referrals for echocardiograms, and manage patient heart sound data through a mobile app and web portal.
View eMurmur ID →Choose EchoNext if…
Choose EchoNext if you need an FDA-cleared AI tool to analyze standard ECGs for the detection of hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. This tool is best suited for broad-access screening in various clinical settings, from major hospitals to community practices, to identify high-risk patients who may require further diagnostic imaging like echocardiograms.
View EchoNext →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | eMurmur ID | EchoNext |
|---|---|---|
| Pricing | Contact vendor | Starts at $600/month |
| Deployment | Mobile and cloud (SaaS), with options for on-premise and hybrid deployments. | Available through the OpenEvidence clinical decision support platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur IDeMurmur ID offers a mobile app and web portal for recording, displaying, and managing heart sounds, and is compatible with various third-party electronic stethoscopes, providing flexibility for users. EchoNext is deployed through the OpenEvidence platform, which is a clinical decision support platform used by many physicians, suggesting a potentially integrated but less direct user experience.
Clinical Value
EchoNextEchoNext has demonstrated superior accuracy in detecting structural heart disease from ECGs compared to cardiologists, even when cardiologists were assisted by AI. It was trained on a massive dataset of over 1.2 million ECG-echocardiogram pairs and has shown high accuracy in identifying a range of structural heart problems. eMurmur ID also shows high sensitivity and specificity in detecting heart murmurs, but EchoNext's ability to detect a broader range of 'hidden' structural heart diseases from a standard ECG, a widely available and inexpensive test, suggests a potentially greater clinical impact.
Pricing & Value
EchoNextEchoNext provides transparent tiered pricing starting at $600/month, with discounts for annual plans and clear details on implementation fees and add-ons. eMurmur ID's pricing is 'contact vendor,' which offers less transparency upfront.
Enterprise Readiness
EchoNextEchoNext is designed for broad access, from major hospitals to community practices, and is deployed through the OpenEvidence clinical decision support platform, which is used by 650,000 U.S. physicians, indicating strong enterprise integration and scalability. eMurmur ID offers mobile and cloud deployment with options for on-premise and hybrid, and is HIPAA compliant with BAA, but its enterprise reach isn't as explicitly detailed.
Innovation
EchoNextEchoNext is highlighted as the world's first FDA-approved AI detection tool that analyzes standard ECGs to detect hidden structural heart disease, a capability previously not possible with ECGs alone. This represents a significant advancement in leveraging a common, inexpensive test for early detection of complex cardiac conditions. eMurmur ID is innovative in its AI-powered heart murmur detection using electronic stethoscopes, but EchoNext's ability to extract such detailed structural information from ECGs is a newer and more disruptive application of AI in cardiology.
Support & Docs
TieNeither the provided structured facts nor the web search results offer specific details about the ongoing customer support, training programs, or comprehensive documentation for either eMurmur ID or EchoNext. While eMurmur mentions 'eMurmur University' and 'eMurmur Primer' for educational purposes, these are distinct from direct product support. Therefore, it is difficult to definitively pick a winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | eMurmur ID | EchoNext |
|---|---|---|
| Tool Name | eMurmur ID | EchoNext |
| Company | CSD Labs GmbH | Pathway Labs |
| Description | AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers. | EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. |
| Key Features | AI-based analytics for heart murmur detection and classification, mobile app for recording and displaying heart sounds, web portal for data management and review, operates with 3rd party electronic stethoscopes, identifies pathologic and innocent heart murmurs, absence of murmur, S1, S2 heart sounds, real-time feedback/analysis results within seconds, patient data management, clinical decision support. | AI-powered ECG analysis, detection of hidden structural heart disease, identifies heart failure risk, screens for valve disease, detects pulmonary hypertension indicators, utilizes standard 12-lead ECGs, FDA-cleared technology, non-invasive diagnostic support. |
| Specialties | Cardiology, Family Medicine, Pediatrics | Cardiology, Family Medicine, Hospital Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring eMurmur ID and EchoNext.